首页 > 市场调查报告书 > 医疗设备

麻醉

市场调查报告书

商品编码

1634172

全球麻醉和呼吸设备市场

Global Anesthesia and Respiratory Devices Market

出版日期: 2025年01月13日 | 出版商:

DataM Intelligence | 英文 176 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

2024年，全球麻醉和呼吸设备市场规模达到540亿美元，预计2033年将达到939.2亿美元，2025-2033年预测期间复合年增长率为6.6%。

麻醉和呼吸设备在当代医疗保健中至关重要，尤其是在手术和重症监护场景中。这些设备可确保患者在需要麻醉或呼吸支持的治疗期间安全舒适。麻醉设备是提供病人麻醉气体和氧气的受控混合物的医疗设备。该设备有助于在手术过程中诱导和维持麻醉，使患者保持无意识和无痛，同时监测和支持其基本功能。呼吸装置包括各种有助于促进或控制无法自行充分呼吸的人的呼吸的设备。这包括呼吸器、氧气输送系统和其他控制肺部气流和气体交换的设备。

对麻醉和呼吸设备的需求不断增长是预测期内推动市场的驱动因素。技术进步提高了设备效率并增加了对麻醉和呼吸设备的需求，这有助于呼吸和麻醉参数的治疗和诊断。例如，2024 年 8 月，Prevounce Health 宣布推出首款用于远端病患监测 (RPM) 的血氧设备 Pylo OX1-LTE。与其他脉搏血氧计相比，经过临床验证的蜂窝连接OX1-LTE 为因慢性呼吸系统疾病（例如慢性阻塞性肺病(COPD) 或哮喘以及各种其他情况）参加RPM 计划的患者提供了众多优势。

市场动态：

驱动程式和限制

对麻醉和呼吸设备的需求不断增加

对麻醉和呼吸设备的需求不断增长预计将成为全球麻醉和呼吸设备市场成长的重要因素。对麻醉和呼吸设备的需求不断增加是由于外科手术数量的增加、呼吸系统疾病的增加、技术的进步、最近的产品发布和批准。

国际上进行的外科手术数量显着增加。随着手术技术的发展和择期手术变得越来越普遍，医疗保健从业者越来越依赖先进的麻醉和呼吸设备来提高病患的安全和结果。这些设备在各种手术过程中提供麻醉、维持呼吸道通畅和辅助呼吸方面发挥重要作用。例如，根据美国国立卫生研究院的数据，美国的手术率范围为每 10 万人 12.0 至 21.4 例手术。

随着慢性阻塞性肺病、气喘和鼻窦炎等慢性呼吸系统疾病在全球变得越来越普遍，先进的麻醉和呼吸设备对于手术和重症监护期间的有效管理是必要的。例如，根据卫生与公共服务部的数据，全球每 20 人就有 1 人患有慢性呼吸道疾病 (CRD)。东亚和南亚的 CRD 死亡率最高。中低和低社会人口指数 (SDI) 国家的 CRD 死亡率年龄标准化率最高。关于慢性呼吸道疾病 (CRD) 的新研究结果显示，它是全球第三大死因，导致全球约 400 万人死亡。这些人中约 60%（约 2.62 亿）被诊断出患有气喘，使其成为最常见的 CRD。自 1990 年以来，CRD 新病例数量增加了 49.0%，这主要是由于人口增长。另一方面，年龄标准化发生率下降了 5.3%。

技术进步在定义市场格局方面发挥着重要作用。製造商正致力于创建便携式网路设备，透过更好的资料管理和监控来改善患者护理。近年来，推出了许多采用最新技术製造的产品。例如，2024年7月，液化空气医疗系统推出了最新的呼吸器Monnal TEO，这代表了机械通气领域的重大进步。该呼吸器专门用于重症监护和重症监护病房，显示致力于改善急性呼吸衰竭患者的护理。

因此，外科手术数量的增加、呼吸系统疾病的增加以及技术的进步增加了对麻醉和呼吸设备的需求并推动了市场。

设备成本高

设备成本高等因素预计将阻碍全球麻醉和呼吸设备市场。成本高的最重要原因之一是生产先进麻醉和呼吸设备的困难。这些小工具通常包含尖端技术，例如人工智慧和复杂的监控系统，这需要大量的研发投资。此外，遵守高监管标准会增加生产成本，因为製造商必须确保其产品符合安全性和功效要求。例如，根据美国国立卫生研究院的数据，与停止通气相比，为基本情况患者提供延长机械通气(PMV) 的每延长生命年的成本为55,460 美元，每个质量调整生命年(QALY) 的成本为82,411 美元。具体来说，PMV 规定下每 QALY 的增量成本超过 100,000 美元。

Anesthesia and respiration devices are vital in contemporary healthcare, especially in surgical and critical care scenarios. These devices keep patients safe and comfortable during treatments that need anesthesia or breathing support. Anesthesia devices are medical devices that administer a controlled mixture of anesthetic gases and oxygen to patients. This equipment aids in the induction and maintenance of anesthesia during surgical procedures, allowing patients to remain unconscious and painless while their essential functions are monitored and supported. Respiratory devices include a variety of equipment that helps facilitate or control breathing for individuals who are unable to breathe sufficiently on their own. This includes ventilators, oxygen delivery systems, and other devices that control airflow and gas exchange in the lungs.

The increasing demand for anesthesia and respiratory devices is the driving factor that drives the market over the forecast period. The technological advancements improve the device efficiency and increase the demand for anesthesia and respiratory devices which helps in the treatment and diagnosis of respiratory and anesthesia parameters. For instance, in August 2024, Prevounce Health announced the launch of its first blood oxygen device for remote patient monitoring (RPM) Pylo OX1-LTE. The clinically validated, cellular-connected OX1-LTE offers numerous advantages over other pulse oximeters for patients enrolled in RPM programs for chronic respiratory conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, and a variety of other scenarios.

Market Dynamics: Drivers & Restraints

Increasing demand for anesthesia and respiratory devices

The increasing demand for anesthesia and respiratory devices is expected to be a significant factor in the growth of the global anesthesia and respiratory devices market. The increasing demand for anesthesia and respiratory devices is due to an increasing number of surgical procedures, an increasing number of respiratory disorders, technological advancements, recent product launches, and approvals.

There has been a significant increase in the number of surgical procedures performed internationally. Healthcare practitioners are increasingly depending on advanced anesthetic and respiratory devices to improve patient safety and results as surgical techniques evolve and elective surgeries become more common. These devices play an important role in providing anesthetic, preserving airway patency, and assisting breathing during various surgical procedures. For instance, according to the National Institute of Health, Surgical rates in the United States ranged from 12.0 to 21.4 surgeries per 100,000 people.

As chronic respiratory conditions like COPD, asthma, and sinusitis become more prevalent globally, advanced anesthesia and respiratory devices are necessary for effective management during surgeries and critical care. For instance, according to the Department of Health & Human Services, 1 in 20 people globally suffers from chronic respiratory disease (CRD). East Asia and South Asia had the highest rates of CRD mortality. Low-middle and low Socio-demographic Index (SDI) countries had the highest age-standardized rates of CRD deaths. New findings on chronic respiratory disease (CRD) now show it is the third leading cause of death globally, accounting for approximately 4 million deaths worldwide. Asthma was diagnosed in approximately 60% of these people (approximately 262 million), making it the most common CRD. Since 1990, the number of new cases of CRDs has increased by 49.0%, owing primarily to population growth. The age-standardized incidence rate, on the other hand, has decreased by 5.3%.

Technological advancements play an important part in defining the market landscape. Manufacturers are concentrating on creating portable and networked equipment that improves patient care through better data management and monitoring. In recent times, there have been many product launches that are manufactured using the latest technology. For instance, in July 2024, Air Liquide Medical Systems launched its latest ventilator, Monnal TEO, which represents a substantial advancement in mechanical ventilation. This ventilator is specifically intended for use in intensive care and critical care units, indicating a commitment to improving patient care in acute respiratory failure conditions.

So, the increasing number of surgical procedures, an increasing number of respiratory disorders, and technological advancements upsurge the demand for anesthesia and respiratory devices and drive the market.

High costs of devices

Factors such as high costs of devices are expected to hamper the global anesthesia and respiratory devices market. One of the most significant reasons for the high costs is the difficulty of producing advanced anesthetic and respiratory devices. These gadgets frequently contain cutting-edge technologies, such as artificial intelligence and complex monitoring systems, which necessitate significant investment in R&D. Additionally, compliance with high regulatory standards raises production costs since manufacturers have to ensure that their products meet safety and efficacy requirements. For instance, according to the National Institute of Health, Providing prolonged mechanical ventilation (PMV) to the base-case patient costs $55,460 for every life-year gain and $82,411 per quality-adjusted life year (QALY) when compared to stopping ventilation. Specifically, the incremental costs per QALY gained under the PMV provision topped $100,000.

Segment Analysis

The global anesthesia and respiratory devices market is segmented based on respiratory equipment, respiratory disposables, respiratory measurement devices, anesthesia machines, anesthesia disposables, end-user, and region.

Oxygen concentrator segment is expected to dominate the global anesthesia and respiratory devices market share

The oxygen concentrator segment is anticipated to dominate the global anesthesia and respiratory devices market due to a number of compelling factors. Oxygen concentrators are widely recognized for their crucial function in providing oxygen supplementation to patients with respiratory diseases. This segment's expansion is primarily driven by the increased prevalence of chronic respiratory disorders, an aging population, and technological improvements that improve the efficiency and effectiveness of these devices.

The number of cases of respiratory disorders is increasing these days due to various factors such as smoking, exposure to air pollution, allergens, and occupational hazards. For instance, according to the American Lung Association, COPD affects 11.7 million adults, resulting in hundreds of thousands of emergency department visits and tens of billions of dollars in healthcare expenses each year. Moreover, according to the Cystic Fibrosis Foundation, Cystic fibrosis affects about 40,000 children and adults in the United States (an estimated 105,000 people have been diagnosed with the disease in 94 countries), and it can affect people of any ethnic background. So, oxygen concentrators play a vital role in providing oxygen supplementation and the demand for oxygen concentrators increases due to increasing respiratory disorders.

Technological advancements have also played a significant part in increasing the demand for oxygen concentrators. Compact designs, lightweight simulations, and user-friendly interfaces have improved the accessibility and usability of these gadgets. For example, portable oxygen concentrators give patients more mobility to engage in daily activities without being attached to fixed equipment. There are recent product launches that use novel technology. For instance, in January 2024, Belluscura, a medical device developer focused on lightweight and portable oxygen enrichment technology, received approval from the Singapore Health Sciences Authority to distribute the X-PLOR portable oxygen concentrator in Singapore.

The use of oxygen concentrators in anesthesia provides greater flexibility and efficiency in controlling patient care. In an emergency or during a power outage, POCs can be used as a backup oxygen source for anesthetic machines, preventing hypoxia and maintaining continuous ventilation. The increasing prevalence of respiratory disorders, technological advancements, and recent product launches and approvals upsurged the demand for oxygen concentrators making this segment the most dominating.

Geographical Analysis

North America is expected to hold a significant position in the global anesthesia and respiratory devices market share

The dominance of the North American market in the global anesthesia and respiratory devices market is due to various factors such as advanced healthcare infrastructure, high prevalence of respiratory diseases, strategic partnerships, product launches and approvals, and increasing adoption of innovative medical technologies.

The increasing prevalence of respiratory disorders in this region increases the demand for respiratory devices. For instance, according to health.gov, respiratory diseases affect millions of people in the United States. More than 25 million people in the United States have asthma. Strategies to reduce environmental triggers and make sure people get the right medications can help prevent hospital visits for asthma. In addition, more than 16 million people in the United States have COPD (chronic obstructive pulmonary disease), which is a major cause of death. Strategies to prevent the disease, like reducing air pollution and helping people quit smoking are key to reducing deaths from COPD.

Due to the presence of top players in this region, strategic partnerships take place to improve the efficiency of various medical devices. For instance, in June 2024, Novair and American Oxygen announced a strategic partnership to develop and market ionic oxygen generators, set to revolutionize the oxygen market. As part of this strategic partnership, Novair will acquire an equity stake in American Oxygen, and the partners will set up a joint venture dedicated to the manufacture of ionic oxygen generators.

In the US, there are recent product launches of anesthesia devices. For instance, in June 2024, SOMNOmedics AG launched its latest anesthesia depth monitoring tool. The NARCOguide is a small and compact stand-alone gadget intended specifically for ambulatory environments. It may be readily mounted in the operation room using a bracket. The device is controlled using the integrated touch display. The display clearly demonstrates all data at a glance, including depth of anesthesia and blood pressure curves for progress control, current depth of anesthesia values, automatic burst suppression detection, oxygen saturation, heart rate, and blood pressure, as well as raw EEG and ECG data.

Asia Pacific is growing at the fastest pace in the global anesthesia and respiratory devices market

The Asia Pacific region is emerging as the fastest-growing market for anesthesia and respiratory devices, owing to a combination of demographic trends, increased healthcare investment, recent launches, an increasing number of surgical procedures, and an increasing prevalence of respiratory diseases.

The increasing prevalence of respiratory diseases is one of the factors that drive the market in this region. For instance, according to The International Primary Care Respiratory Group, India has one of the highest rates of chronic respiratory illness. India accounts for 15.69% of worldwide chronic respiratory diseases, whereas 30.28% of all global deaths from chronic respiratory diseases occur in India. India has the world's greatest number of COPD (Chronic Obstructive Pulmonary Disease) cases, totaling 55.23 million. India has the second-highest number of COPD-related deaths globally, accounting for almost 0.85 million.

There are recent product launches of anesthesia devices in this region. For instance, according to an article published by the Times of India in June 2024, Renowned Indian data scientists have created a new AI-powered anesthetic monitoring system in India that will enable real-time, full analysis of physiological data during surgical procedures. The new AI-powered system uses machine learning algorithms to handle data from many sources, such as EEG, ECG, and pulse oximetry, assuring accurate and timely monitoring.

Competitive Landscape

The major global players in the global anesthesia and respiratory devices market include GE HealthCare, Medtronic, Teleflex Incorporated, Koninklijke Philips N.V., Dragerwerk AG & Co. KGaA, Getinge AB, Smiths Group plc, Fisher & Paykel Healthcare Limited., ResMed, Inogen, Inc. among others.

Emerging Players

Aerin Medical, Circadia Health, and SeaStar Medical among others

Key Developments

In August 2023, VGM & Associates signed a new vendor agreement with O2 Concepts. With O2 Concept's innovative POC portfolio and revolutionary DNA platform, they enhance the ability to meet the evolving needs of VGM members and patients. This partnership is a step forward in our commitment to delivering exceptional respiratory solutions.
In January 2023, OxyGo, makers of portable oxygen concentrators, launched a new sleep line, complete with a CPAP, BPAP, PAP accessories, and a web-based adherence portal. The cloud provider portal gives providers secure web access to manage and monitor patient data. Providers will also have the ability to share data and statistics with physicians and other healthcare professionals. The portal works with 1st-generation OxyGo CPAP and BPAP models via card-to-cloud and will also connect with the newly available 2nd-generation Wi-Fi models.
In January 2024, Schiller Healthcare India Pvt. Ltd. launched the A-mac series, marking a significant advancement in the field of anesthesia technology in India. This new series of anesthesia workstations aims to enhance the quality and efficiency of anesthesia delivery in various medical settings, particularly in hospitals and intensive care units (ICUs).

Why Purchase the Report?

Pipeline & Innovations: Reviews ongoing clinical trials, product pipelines, and forecasts upcoming advancements in medical devices and pharmaceuticals.
Product Performance & Market Positioning: Analyzes product performance, market positioning, and growth potential to optimize strategies.
Real-World Evidence: Integrates patient feedback and data into product development for improved outcomes.
Physician Preferences & Health System Impact: Examines healthcare provider behaviors and the impact of health system mergers on adoption strategies.
Market Updates & Industry Changes: Covers recent regulatory changes, new policies, and emerging technologies.
Competitive Strategies: Analyzes competitor strategies, market share, and emerging players.
Pricing & Market Access: Reviews pricing models, reimbursement trends, and market access strategies.
Market Entry & Expansion: Identifies optimal strategies for entering new markets and partnerships.
Regional Growth & Investment: Highlights high-growth regions and investment opportunities.
Supply Chain Optimization: Assesses supply chain risks and distribution strategies for efficient product delivery.
Sustainability & Regulatory Impact: Focuses on eco-friendly practices and evolving regulations in healthcare.
Post-market Surveillance: Uses post-market data to enhance product safety and access.
Pharmacoeconomics & Value-Based Pricing: Analyzes the shift to value-based pricing and data-driven decision-making in R&D.

The global anesthesia and respiratory devices market report delivers a detailed analysis with 60+ key tables, more than 50 visually impactful figures, and 176 pages of expert insights, providing a complete view of the market landscape.

Target Audience 2024

Manufacturers: Pharmaceutical, Medical Device, Biotech Companies, Contract Manufacturers, Distributors, Hospitals.
Regulatory & Policy: Compliance Officers, Government, Health Economists, Market Access Specialists.
Technology & Innovation: AI/Robotics Providers, R&D Professionals, Clinical Trial Managers, Pharmacovigilance Experts.
Investors: Healthcare Investors, Venture Fund Investors, Pharma Marketing & Sales.
Consulting & Advisory: Healthcare Consultants, Industry Associations, Analysts.
Supply Chain: Distribution and Supply Chain Managers.
Consumers & Advocacy: Patients, Advocacy Groups, Insurance Companies.
Academic & Research: Academic Institutions.

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Respiratory Equipment
3.2. Snippet by Respiratory Disposables
3.3. Snippet by Respiratory Measurement Devices
3.4. Snippet by Respiratory Anesthesia Machines
3.5. Snippet by Respiratory Anesthesia Disposables
3.6. Snippet by End-User
3.7. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
- 4.1.2. Increasing Demand for Anesthesia and Respiratory Devices
- 4.1.3. Restraints
- 4.1.4. High Costs of Devices
- 4.1.5. Opportunity
- 4.1.6. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Reimbursement Analysis
5.6. Patent Analysis
5.7. SWOT Analysis
5.8. DMI Opinion

6. By Respiratory Equipment

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 6.1.2. Market Attractiveness Index, By Respiratory Equipment
6.2. Humidifiers*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Nebulizers
6.4. Oxygen Concentrator
6.5. Positive Airway Pressure Devices
6.6. Ventilators
6.7. Reusable Resuscitators

7. By Respiratory Disposables

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 7.1.2. Market Attractiveness Index, By Respiratory Disposables
7.2. Disposable Oxygen Masks*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Tracheostomy Tubes
7.4. Oxygen Cannula

8. By Respiratory Measurement Devices

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 8.1.2. Market Attractiveness Index, By Respiratory Measurement Devices
8.2. Pulse Oximetry Systems*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Capnographs
8.4. Spirometers
8.5. Peak Flowmeters

9. By Anesthesia Machines

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 9.1.2. Market Attractiveness Index, By Anesthesia Machines
9.2. Anesthesia Workstation*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Anesthesia delivery machines
9.4. Anesthesia Ventilators
9.5. Anesthesia Monitors

10. By Anesthesia Disposables

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 10.1.2. Market Attractiveness Index, By Anesthesia Disposables
10.2. Anesthesia Masks*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Anesthesia Accessories

11. By End User

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 11.1.2. Market Attractiveness Index, By End User
11.2. Hospitals*
- 11.2.1. Introduction
- 11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Ambulatory Service Centres
11.4. Homecare

12. By Region

12.1. Introduction
- 12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 12.1.2. Market Attractiveness Index, By Region
12.2. North America
- 12.2.1. Introduction
- 12.2.2. Key Region-Specific Dynamics
- 12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.2.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.2.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.2.9.1. The U.S.
  - 12.2.9.2. Canada
  - 12.2.9.3. Mexico
12.3. Europe
- 12.3.1. Introduction
- 12.3.2. Key Region-Specific Dynamics
- 12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.3.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
- 12.3.9. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.3.9.1. Germany
  - 12.3.9.2. UK
  - 12.3.9.3. France
  - 12.3.9.4. Italy
  - 12.3.9.5. Spain
  - 12.3.9.6. Rest of Europe
12.4. South America
- 12.4.1. Introduction
- 12.4.2. Key Region-Specific Dynamics
- 12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.4.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.4.8.1. Brazil
  - 12.4.8.2. Argentina
  - 12.4.8.3. Rest of South America
12.5. Asia-Pacific
- 12.5.1. Introduction
- 12.5.2. Key Region-Specific Dynamics
- 12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.5.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 12.5.8.1. China
  - 12.5.8.2. India
  - 12.5.8.3. Japan
  - 12.5.8.4. South Korea
  - 12.5.8.5. Rest of Asia-Pacific
12.6. Middle East and Africa
- 12.6.1. Introduction
- 12.6.2. Key Region-Specific Dynamics
- 12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Equipment
- 12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Disposables
- 12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Respiratory Measurement Devices
- 12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Machines
- 12.6.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Anesthesia Disposables
- 12.6.8. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

13. Competitive Landscape

13.1. Competitive Scenario
13.2. Market Positioning/Share Analysis
13.3. Mergers and Acquisitions Analysis

14. Company Profiles

14.1. GE HealthCare*
- 14.1.1. Company Overview
- 14.1.2. Product Portfolio and Description
- 14.1.3. Financial Overview
- 14.1.4. Key Developments
14.2. Medtronic
14.3. Teleflex Incorporated
14.4. Koninklijke Philips N.V.
14.5. Dragerwerk AG & Co. KGaA
14.6. Getinge AB
14.7. Smiths Group plc
14.8. Fisher & Paykel Healthcare Limited.
14.9. ResMed
14.10. Inogen, Inc.

LIST NOT EXHAUSTIVE